| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Beam Therapeutics Inc. (BEAM) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. BEAM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $32.08M | - | |
| Pres | 218.4K | $6.93M | - | |
| Other | 109.7K | $3.48M | - | |
| Other | 77.4K | $2.45M | - | |
| CFO | 73.7K | $2.34M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | Cavanagh Bethany J46 | SVP, Finance And Treasurer | Sell | 1,117 | $24.68 | $27,567.56 | -2.5% | -25.2% | +9.9% | |
| Nov 6, 2024 | Ciaramella Giuseppe77 | President | Sell | 51,110 | $26.36 | $1,347,050.05 | -31.9% | -3.3% | -13.0% | |
| Oct 14, 2024 | Ciaramella Giuseppe77 | President | Sale+OE | 51,110 | $26.27 | $1,342,751.70 | -24.2% | -3.9% | -4.4% | |
| Oct 1, 2024 | Bellon Christine58 | Chief Legal Officer | Sell | 385 | $23.48 | $9,039.57 | -0.4% | +7.9% | +3.1% | |
| Oct 1, 2024 | Cavanagh Bethany J46 | SVP, Finance And Treasurer | Sell | 289 | $23.48 | $6,785.46 | -0.6% | +7.9% | +3.1% | |
| Sep 30, 2024 | Evans John M.70 | CEO | Sell | 60,000 | $24.60 | $1,476,024.00 | -6.0% | +3.1% | -0.9% | |
| Jul 2, 2024 | Simon Amy59 | Chief Medical Officer | Sell | 1,250 | $23.28 | $29,094.12 | -0.9% | +8.6% | -11.9% | |
| Jun 27, 2024 | Evans John M.70 | CEO | Sell | 60,000 | $24.50 | $1,470,156.00 | -5.7% | +2.2% | -29.9% | |
| Apr 2, 2024 | Simon Amy59 | Chief Medical Officer | Sell | 23,687 | $31.02 | $734,805.41 | -13.1% | -24.5% | -39.5% | |
| Apr 1, 2024 | Evans John M.70 | CEO | Sell | 18,102 | $32.13 | $581,617.26 | -1.7% | -29.4% | -46.0% |